FrameWORX – BioCrossroads

Indiana’s Medical Device Advantage Was Built.
Keeping It Will Require Us to Build Faster.

Indiana did not become a leader in medical devices by accident. Its position was built over decades through manufacturing expertise, scientific discovery, entrepreneurship, workforce development, and a willingness to solve difficult problems.

But leadership is not permanent.

At BioCrossroads’ August FrameWORX program in Bloomington, more than 160 leaders from industry, academia, healthcare, workforce development, and economic development came together to consider what Indiana must do to ignite its next wave of medical device growth.

The day began with tours of Cook Medical, Simtra BioPharma Solutions, and Singota Solutions before moving to Ivy Tech Bloomington for a series of conversations spanning diagnostics, minimally invasive technologies, implantables, orthopedics, advanced manufacturing, talent, and regional growth.

Together, those conversations pointed to a clear conclusion: Indiana has the assets to lead, but its future position will depend on how quickly and intentionally it puts them to work.

Starting from a position of strength

Indiana’s medical device sector employs more than 18,000 people, with jobs concentrated at approximately twice the national rate. The state has distinct strengths across three major areas of the industry: diagnostics, minimally invasive technologies, and implantable devices, including orthopedics.

Global companies such as Roche Diagnostics, Cook Medical, Boston Scientific, and Zimmer Biomet operate alongside emerging companies, research institutions, healthcare systems, and specialized manufacturing partners. Indiana is also home to nationally recognized biomedical engineering, biotechnology, and workforce-training programs.

Recent investments demonstrate what can happen when those assets are connected.

The newly awarded National Science Foundation Regional Innovation Engine focused on musculoskeletal health brings together more than 170 partners from industry, research, clinical care, and higher education. The initiative will receive an initial $15 million, with the potential for as much as $160 million over 10 years.

It is a significant opportunity to extend Indiana’s orthopedic expertise beyond any single company or community and build a more connected statewide innovation ecosystem.

Still, the data also underscores the urgency of the work ahead. From 2018 to 2022, medical device employment in Indiana declined by approximately 6 percent. From 2010 to 2020, Indiana recorded the lowest medical device GDP growth among the 50 states.

Other states and countries are moving quickly to attract the same companies, investment, innovation, and talent.

Indiana cannot rely on the strength of its history to secure its future.

In his keynote address, Cook Group and Cook Medical President Pete Yonkman challenged attendees to consider whether institutions, companies, and communities have become too accustomed to studying opportunities instead of acting on them.

He described this pattern as “drift,” a gradual movement away from building and toward waiting, planning, and avoiding risk.

Yonkman illustrated the idea through a recent conversation with Cook Medical interns. When asked how they felt about artificial intelligence, most expressed concern. They worried about jobs, their career paths, and the wider effects of the technology. At the same time, every intern acknowledged using AI.

Their perspective began to change when the conversation moved away from what AI might do to them and toward what they could build with it.

Cook Medical is already using AI to evaluate device designs, monitor manufacturing processes, reduce the potential for quality problems, and accelerate product development. When the interns saw how the technology could help them solve meaningful problems, fear gave way to curiosity.

The lesson extends well beyond AI.

People become more confident with unfamiliar tools when they have an opportunity to use them, learn from mistakes, and see how their work contributes to a larger purpose. Companies and communities develop the ability to build by building.

Yonkman left the audience with a question that carried through the remainder of the program: What would it take for Indiana to become the fastest-learning and fastest-building life sciences ecosystem in the country?

Innovation requires more than an idea

Across four panel discussions, industry and ecosystem leaders explored how that challenge is playing out throughout the medical device sector.

In diagnostics, advances in precision medicine, biomarker discovery, automation, and data are making it possible to identify diseases earlier and connect patients with treatment more quickly. Capturing that opportunity requires closer relationships among researchers, entrepreneurs, diagnostic companies, healthcare providers, investors, and regulatory experts.

For minimally invasive devices, innovation increasingly depends on the ability to combine disciplines. Smaller and more precise devices are being developed alongside advances in imaging, robotics, artificial intelligence, materials science, and advanced manufacturing.

The opportunity is significant, but moving a product from an early concept to patient care remains expensive and complex. Entrepreneurs need access to experienced mentors, clinical partners, capital, manufacturing capabilities, and leaders who understand how to navigate regulatory and commercialization pathways.

Indiana has many of those resources. The greater challenge is making them easier to find and connect.

The discussion of implantables and orthopedics offered a tangible example of what that connection can produce. Indiana’s emerging musculoskeletal innovation engine is creating a structure through which researchers, manufacturers, clinicians, entrepreneurs, and workforce partners can pursue opportunities together.

That model reflects a theme heard throughout the day: Indiana is strongest when it operates as an ecosystem rather than a collection of individual assets.

Growth also depends on place

The program concluded by focusing on the Indiana Uplands, an 11-county region where life sciences account for approximately 16 percent of total employment.

The region has an unusual concentration of assets, including major life sciences employers, Indiana University, Ivy Tech Community College, Naval Surface Warfare Center Crane, entrepreneurship resources, and experienced workforce and economic development organizations.

But companies cannot grow where people cannot build lives.

Housing, infrastructure, education, quality of place, and access to career opportunities are all part of a competitive life sciences strategy. The Uplands conversation reinforced that industry growth and community growth cannot be treated as separate priorities.

Indiana must create places where companies can expand, entrepreneurs can build, and people can see a future for themselves and their families.

The next advantage will be built together

Indiana already possesses many of the capabilities needed to lead the next generation of medical devices. It can invent new technologies, make them at scale, and move them to patients around the world.

The question is whether the state can connect those capabilities and move with the speed the moment requires.

That means giving people the tools to experiment and learn. It means helping promising ideas cross the distance between research and commercialization. It means strengthening the communities that support companies and workers. And it means replacing institutional drift with a shared willingness to build.

Indiana’s medical device advantage was built by people who saw what was possible and acted.

Its next wave of growth will be built the same way.

2026 FrameWorx series

A Platform for Progress

Each FrameWORX event brings Indiana’s life sciences community together around the critical topics that require shared expertise, new partnerships, and coordinated action. Through focused discussion and meaningful connection, FrameWORX helps turn shared expertise into new ideas, partnerships, and progress.

Transforming Cancer Care through Indiana’s Innovation Ecosystem

Advancing Indiana’s Life Sciences Innovation Ecosystem

Medical Devices in Indiana: Igniting the Next Wave of Growth

FrameWORX: Advancing Indiana’s Life Sciences and Healthcare Workforce

All Roads Led to Warsaw:
BioCrossroads FrameWORX Highlights Indiana’s Orthopedic Leadership

Known globally as the Orthopedic Capital of the World®, the region welcomed more than 200 scientists, researchers, business leaders, and students for BioCrossroads’ quarterly FrameWORX event: The Future of Musculoskeletal Health: Innovations in Orthopedic Medicine and Indiana’s Leadership Opportunity. Held at Grace College in Winona Lake, Indiana the event placed Indiana’s orthopedic strength in the spotlight by bringing national voices together to discuss the science, industry, and impact of musculoskeletal health.

Orthopedics is one of the most important sectors in global health, providing implants, devices, and treatments that restore mobility, reduce pain, and extend quality of life for millions of patients. Warsaw has long been at the center of that mission. It is home to global leaders like Zimmer Biomet and J&J MedTech, alongside a thriving community of mid-sized companies, startups, suppliers, and innovators who design and manufacture orthopedic technologies that are used worldwide. Tens of thousands of Hoosiers work in this industry, making Indiana one of the largest concentrations of musculoskeletal expertise and production on the planet.

Article content — *J&J MedTech was one of many partners represented at the FrameWORX event at Grace College.*

The state’s academic and research institutions are also pushing the field forward. Purdue University is applying artificial intelligence to orthopedic product development, while the IU School of Medicine continues to make groundbreaking discoveries through the Indiana Center for Musculoskeletal Health. Under the leadership of Dr. Melissa Kacena, the Center is working to secure a 10-year National Science Foundation award that could transform the state’s innovation economy. Indiana is a semifinalist for a grant that would expand STEM education for thousands of students, train nearly 2,000 people, launch dozens of new companies, bring new products to market, file hundreds of patents, create thousands of jobs, and generate more than half a billion dollars in economic impact. Just last year, Indiana continued its orthopedic momentum by approving a $30 million investment in the Orthopedic Industry Retention Initiative, a targeted effort to strengthen infrastructure, support workforce programs, and secure the long-term competitiveness of the region’s orthopedic sector.

The FrameWORX event reflected this momentum. Attendees heard from orthopedic oncologist and cancer survivor Dr. Kurt Weiss, who shared both clinical expertise and personal perspective on why advances in orthopedic medicine matter so profoundly. Dr. Weiss facilitated a panel with orthopedic patients whose voices offered a moving reminder of how these innovations change lives in real time. Industry and academic leaders from Zimmer Biomet, Purdue University, and IU Indianapolis spoke about how robotics, precision engineering, and data-driven research are reshaping orthopedic care. Leaders in manufacturing and workforce development discussed how Indiana is building the infrastructure and training the talent needed to sustain this global industry well into the future.

The program also featured perspectives from beyond Indiana. Dr. Hicham Drissi, professor and vice chair of research at Emory University School of Medicine and President-Elect of the Orthopaedic Research Society, praised Indiana’s collaborative spirit, remarking that “it takes two hands to clap” and that Warsaw’s energy and talent make it an ideal incubator for global growth.

Brandon Noll, Director of Plug & Play Indiana, underscored the state’s unique identity when he told the audience, “We’re not looking to be the Silicon Valley of Med Tech. We’re looking to be Med Tech Valley.”

Though Warsaw may be tucked away in northeast Indiana, far from major media hubs, its orthopedic impact resonates worldwide. Every day, thousands of professionals here are innovating, manufacturing, and delivering devices that improve lives across every continent. On August 20, the FrameWORX event showcased this global significance, while also pointing to even greater opportunities ahead.

“The musculoskeletal health sector is one of Indiana’s strongest global assets,” said Vince Wong, President and CEO of BioCrossroads. “This event underscored the extraordinary innovation happening here, the collaboration that drives it, and the opportunity for Indiana to continue leading the world in orthopedic medicine.”

Winners of the poster content held in conjunction with the FrameWorx event. — *Keynote speaker Dr. Kurt Weiss delivered moving remarks about his personal journey* *and*

Photos from FrameWORX

Thank you to our sponsors

Watch the full FrameWORX recap.

FrameWORX: Translating Research into Marketable Solutions

Collaboration often is the key to success in business. And when it comes to life sciences, you can double down. Numerous functions and areas of expertise are needed to transform an idea into reality, and we learned more about Indiana’s ability to partner our way to life sciences leadership at our latest FrameWORX on March 13.

First, some context: Indiana has been a life sciences leader for decades. Eli Lilly and Company was founded in 1876 and for decades ushered through innovations that address diabetes, depression, schizophrenia, Alzheimer’s, obesity, and other challenging conditions.

Today, Indiana leads the U.S. in pharmaceutical exports and we’re No. 2 in life sciences exports. Our life sciences industry contributes $95 billion toward the Hoosier State’s economy and Indiana ranks among the top 5 states in life sciences employment.

Unleashing innovation is leading to strong growth – and commercializing scientific opportunities is paramount to achieving next-generation success. But going it alone – regardless of your size, strength, or location – is rarely optimal in the life sciences. Leaders from academia and industry alike talked about leveraging the newest opportunities before a capacity FrameWORX crowd at 16 Tech.

Critical to Indiana’s growth opportunities are organizations and resources that facilitate success. BioCrossroads has been around for more than two decades and has supported much of Indiana’s recent growth by facilitating funding and collaboration that fuel our state’s work.

We kicked off the event with a candid conversation about innovation and entrepreneurship in Indiana’s life sciences sector. Moderated by BioCrossroads’ Chief Innovation Officer Mike Bolinder, the panel featured Diana Caldwell of Amplified Sciences, Richard Church of Parkview Health, and Derek Small of Luson Bioventures. Each brought a unique perspective—startup founder, health system leader, and investor—but all emphasized the same truth: bringing a breakthrough to market takes more than a good idea. It takes a strong network, trusted partnerships, and an ecosystem that understands both the science and the business behind innovation. From early lessons learned to the value of local collaborations, the discussion offered a powerful reminder of why Indiana continues to be a launchpad for life sciences success.

Key leaders coming from academia joined the conversation including David Rosenberg, president and CEO of IU Launch Accelerator for Biosciences or IU LAB, David Umulis, senior vice provost for Purdue University in Indianapolis and director of the EMBRIO Institute, and Paul Bohn, director of the Bioengineering and Life Sciences (BELS) Initiative at the University of Notre Dame. We also heard from Alan Palkowitz, president and CEO of the Indiana Biosciences Research Institute, who underscored the importance of moving quickly in today’s competitive environment.

“We need to invest and move quickly,” he said “We need to move forward with detail, with robust data, and reveal gaps that need to be filled. We also need to ask ourselves: what is the best quality product to move forward?”

Hoosier companies and innovators have important resources at their fingertips. Collectively, we find ways to turn ideas into innovation … and turn innovation into commercial success. We’ll be talking more about these organizations and how they support Hoosier innovators in the months ahead.

2025 FrameWORX Series: Driving Indiana’s Life Sciences Forward

For more than two decades, BioCrossroads has brought together Indiana’s life sciences community—fueling collaboration, innovation, and industry growth. This year, we’re excited to unveil the 2025 FrameWORX series: a platform to ignite dialogue and discover solutions for the next generation of life sciences. From accelerating research commercialization to supporting specialized areas like orthopedics and nuclear medicine, FrameWORX is designed to bring diverse stakeholders—entrepreneurs, researchers, educators, and policymakers—into the same room to tackle emerging challenges and opportunities head-on.

March 13: Innovation and Industry Growth – Translating Research into Marketable Solutions

Great science is only the first step. Converting groundbreaking discoveries into practical applications requires strong networks, targeted resources, and a supportive ecosystem. This session will explore how to effectively move ideas from the lab to the marketplace—highlighting the role Indiana plays in fostering entrepreneurship and industry growth.

June 12: Workforce Resilience in Life Sciences – Retaining Top Talent in a Competitive Market

A skilled and adaptable workforce is essential to maintaining Indiana’s leadership in life sciences. This discussion will focus on workforce development efforts, innovative training models, and strategies for attracting and retaining top talent. In an increasingly competitive environment, resilient and well-prepared professionals are more important than ever.

August 20: Warsaw/Orthopedic Capital of the World

Indiana’s orthopedic sector is a global leader in musculoskeletal innovation and medical device manufacturing. Hosted in Warsaw—often referred to as the “Orthopedic Capital of the World”—this session will showcase advancements in orthopedics, while examining how continued investment, cutting-edge research, and strategic collaboration are shaping the future of this vital sector.

Registration will open soon for August FrameWORX

December 4: Nuclear Medicine Manufacturing and Our Growing Opportunities

As nuclear medicine continues to advance, Indiana has an opportunity to further establish itself as a leader in this high-growth sector. This session will delve into the state’s expanding role in manufacturing, research, and workforce development to meet the growing demand for radiopharmaceuticals and nuclear medicine technologies.

As we look ahead to 2025, we invite you to make your voice heard. FrameWORX is more than a series of events; it’s an open forum where ideas turn into plans and plans turn into action.

Join us throughout the year for these dynamic sessions, connect with peers, and help shape the future of Indiana’s life sciences sector.

We can’t wait to see you there!

Back to FrameWORX

A Glimpse into the Future of Nuclear Medicine

Our FrameWORX series this year has been a fascinating journey through the pillars of our strategic life sciences plan for Indiana. Our final event of the year – held earlier this month at the Indiana Biosciences Research Institute – can feel like a big gulp of science. But no area captures Indiana’s life sciences growth like nuclear medicine and radiopharmaceuticals.

Indiana leads the nation in conventional pharmaceutical exports, and at least 14 life sciences companies today are developing and manufacturing radiopharmaceuticals – propped by our state’s central location and logistics expertise. Decades of life sciences leadership are complemented by the logistics required to produce treatments and diagnostics that leave little room for shelf life. Radioactive materials degrade quickly, and each dose must reach the intended patient within 3 to 5 days from production. Indiana’s FedEx hub, the second largest in the world, is a major advantage – as is the fact Central Indiana is a 12-hour drive from approximately half the U.S.

Indiana is on the leading edge of a booming technology. Nuclear medicine is a $6 billion industry in the U.S. and is expected to triple in the next 7 years. Heartland BioWorks, designated a regional technology and innovation hub by the federal Economic Development Administration, has established BioTrain, an institute designed to prepare talent for entry-level biomanufacturing roles. BioTrain will be located at the 16 Tech Innovation District. And just north of Indianapolis, Purdue has the nation’s largest nuclear medicine pharmacy program in the country.

As demonstrated at our FrameWORX, radiopharmaceuticals are used in nuclear medicine imaging and procedures – particularly for prostate and other cancers. They are administered systemically, but their biomolecular properties cause them to localize in specific tissues. Years ago, doctor might use a sledgehammer approach to treatment – in other words, diagnose and treat a large swath of the body to address diseases that were challenging to pinpoint. Radiopharmaceuticals are more like using an arrow and bull’s eye. Precision leads to less invasiveness and more precise treatments for patients.

Researchers and business leaders from IU School of Medicine, Purdue, life sciences companies, and the patient advocacy world drove a robust discussion about the future of radiopharmaceuticals. Perhaps no one said it better than Geoff Towle, a vice president and senior general manager at Novartis. Geoff joined us from his New Jersey headquarters because his company has built a large radiopharmaceutical manufacturing plant in Indianapolis.

“This feels like reimagining medicine,” he said. “Nuclear medicine is incredibly effective and exquisitely targeted. Patients are waiting for this and that’s what we need to focus on.”

Thank you to our December FrameWORX Presenting Sponsor

Leading by Example: Life Sciences Manufacturing in Indiana

From Development to Delivery: Indiana’s Edge in Life Sciences Manufacturing

Indiana’s heritage in life sciences manufacturing dates back more than 100 years. In 1923, Eli Lilly and Company became the first-ever organization to mass produce insulin for patients living with diabetes—helping change the trajectory of countless lives around the world.

Indiana stands as a leader in manufacturing, drawing envy from states nationwide. Our state leads the nation in pharmaceutical exports and holds the second place in exporting life sciences products. The path ahead is marked by significant opportunities, such as Lilly’s $9 billion manufacturing pledge in Boone County, our pioneering role in radiopharmaceutical manufacturing, and Ivy Tech’s recent unveiling of a 4,000-square-foot Biopharma Science and Technology Lab. These developments position Indiana at the forefront of potential growth, provided we maintain our focus and continue to drive forward with unwavering commitment.

Our latest FrameWORX discussion on manufacturing was held before an overflow crowd on June 20 in the Fishers Life Sciences and Innovation District, another Central Indiana community that is booming with life sciences jobs.

Our host, INCOG BioPharma Services, has been around less than five years and recently received FDA approval for a new sterile injectable facility, positioning the company as an emerging contract manufacturing leader. Our other guests – representing diverse organizations such as Lilly, Purdue, IEDC, Langham Logistics, and Stevanato Group – agreed that Indiana’s leadership was underscored by the diverse and engaged crowd that showed up to learn and discuss how we can sharpen our skills.

There’s no finish line when it comes to life sciences manufacturing. Like the rest of the world, technology and customer needs are moving fast: AI, digital twins, and continuous manufacturing are evolving quickly, and Hoosier companies must keep up. Other states want what we have here – but we must keep the conversation going.

Thank you to our expert panelists:

Riccardo Butta, President – Americas, Stevanato Group
Cory Lewis, CEO and President, INCOG BioPharma Services
Brooke Kendzicky, Sr. Director, Global Supply Chain Resiliency & Sustainability, Eli Lilly and Company
Leanne Merriman, Director of Customer Experience, Langham Logistics
Dr. Elizabeth Topp, Director, William D. and Sherry L. Young Advanced Manufacturing of Pharmaceuticals Institute
Jessica Tower, VP of Attractions, Indiana Economic Development Corporation

Thank you to our series title sponsors, Faegre Drinker, as well as our presenting sponsors and hosts for this event, INCOG BioPharma Services.

Join us on September 18 for our next FrameWORX, Fueling the Future: Indiana’s Life Sciences Workforce.

Bob Vitoux, president and chief executive officer of OrthoWorx – which works to advance the thriving orthopedic industry in Warsaw – shared a revealing story last week during our May FrameWORX at 16 Tech.

Plug and Play, a leading global innovation platform that connects startups with corporations, governments, and organizations to drive innovation and create mutually beneficial partnerships, held a ribbon-cutting ceremony for a new MedTech office in Warsaw – supporting a community that already is the Orthopedic Capital of the World. Among the dignitaries in attendance was Gov. Eric Holcomb. He told the audience: “Indiana used to be a flyover state. Now, fly over at your own peril.”

Wise words – relevant not only to the growth we’re seeing in Warsaw but across Indiana.

The life sciences are seeing significant traction across the U.S. and Indiana is right in the mix. Life sciences organizations here secured $5.5 billion in capital and investments last year while making a $95 billion contribution to the state’s economy. And key stakeholders, who are playing a crucial role in that growth, joined our May FrameWORX, sharing insights into one of Indiana’s real strengths: our life sciences hubs and collaboration across the Hoosier State.

The hubs were represented by Warsaw, West Lafayette, and Bloomington. Warsaw is a real success story that should make all Hoosiers proud with world-leading orthopedic manufacturers sprinkled across a beautiful community in northeast Indiana. Bloomington and West Lafayette are leveraging unique opportunities with leading universities in their backyards. Indiana University secured $772 million in sponsored research awards in 2023 and is investing $250 million in biosciences – including a $60 million investment into expanded new lab and research space.

In West Lafayette, meanwhile, Purdue has the No. 1 nuclear pharmacy program in the nation and received a record-breaking $613 million in research funding in fiscal year 2023. Lafayette is also third in the U.S. among medium-sized metropolitan areas for drug and pharma employment.

Collectively, our life sciences clusters are advancing Indiana’s workforce, economy, and innovation that help people with needs everywhere. We’ll take another look at our sector on June 20 through the lens of advanced manufacturing and how Indiana is filling important gaps. And we’re taking our show on the road to the Fishers Life Sciences and Innovation District where we’ll visit INCOG BioPharma Services, a state-of-the-art contract development manufacturing organization.

Join us on June 20 for FrameWORX – From Development to Delivery: Our Edge in Life Sciences Manufacturing

BioCrossroads is excited to announce FrameWORX: Innovating Across Indiana: The Strengths of Our Regional Life Sciences Hubs on Wednesday, May 8 at the Indiana Biosciences Research Institute.

This event will bring together key experts representing regional innovation hubs across Indiana, showcasing the groundbreaking achievements and future potential of our state’s innovation hubs. They will share insights into the innovation, collaboration, and advancements happening across Indiana’s life sciences ecosystem, thanks to these collective and focused regional efforts.

Speakers will include:

Vincent Jo Davisson, Founder and Chief Scientific Officer, Amplified Sciences
John Fernandez, Senior Vice President, Innovation & Strategic Partnerships, The Mill Bloomington
Jim Lancaster, President, Global Reconstruction Business, Zimmer Biomet
Ben Larson, Director of Manufacturing, Evonik
Eric Munson, Head of Industrial and Molecular Pharmaceuticals, Purdue University
Rahul Shrivastav, Executive Vice President and Provost, Indiana University Bloomington
Bob Vitoux, President and CEO, OrthoWorx

FrameWORX: Innovating Across Indiana: The Strengths of Our Regional Life Sciences Hubs
Wednesday, May 8
3:30-5:30 p.m.
Indiana Biosciences Research Institute

Future FrameWORX Events

BioCrossroads is thrilled to announce the 2024 lineup of FrameWORX events. This year, each event will highlight a key component of the recently released Strategic Roadmap for Advancing Indiana Life Sciences.

Released in early January 2024, the Strategy was crafted in collaboration with TEConomy Partners and provides a framework for transforming Indiana’s life sciences landscape, focusing on four pivotal areas:

Fostering research and development and innovation
Enhancing the state’s life sciences manufacturing ecosystem
Boosting Indiana’s life sciences talent and workforce
Supporting connections and outreach across the sector

The first FrameWORX of 2024 is Igniting an Industry: Indiana’s Life Sciences Strategy and will take place on March 13 at 3:30 p.m., with networking from 5:00-5:30 p.m.

Additional 2024 FrameWORX events:

May 8 – Innovating Across Indiana: The Strengths of Our Regional Life Sciences Hubs

June 20 – From Development to Delivery: Indiana’s Edge in Life Sciences Manufacturing

September 18 – Fueling the Future: Indiana’s Life Sciences Workforce

December 4 – Nuclear Medicine: Indiana’s Future in Life Sciences

These events are open to the public and there is no cost to attend, although registration is required for each date.

FrameWORX was established by BioCrossroads as an educational and networking platform to fuel growth, learning, and connectivity within Indiana’s thriving life sciences ecosystem. These events provide a hub for engaging thought leaders, offering diverse viewpoints, and fostering enhanced collaboration among the state’s research institutions, philanthropic organizations, and enterprises.

Indiana’s Medical Device Advantage Was Built. Keeping It Will Require Us to Build Faster.